Lantheus
LNTH · NASDAQ
Bulios Fair Price
$136.68
36.7% upside
Trenutna cena
$100
Po podatkih Bulios Fair Price je delnica LNTH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Lantheus Holdings, Inc. is a U.S.-based biotechnology company specializing in the development and manufacturing of diagnostic and therapeutic products, particularly in the fields of oncology and cardiology. Founded in 1956 and headquartered in North Billerica, Massachusetts, Lantheus is known for its innovative technology in imaging diagnostic products, such as contrast agents and radiopharmaceuticals, which enable doctors to effectively diagnose and treat a variety of health conditions, including cancer and heart diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mary Anne Heino
Employees
1,193
Headquarters
Bedford
Prihajajoči dogodki
Earnings
Upcoming earnings report